Help fight the fastest increasing cause of cancer mortality in Australia
A problem doesn’t go away if you ignore it, and liver cancer has been ignored by the general public for far too long.
We’ve reached the point where liver cancer is the fastest increasing cause of cancer mortality in Australia. It also sits as the third most common cause of cancer death, worldwide.
1,643 people a day are dying of liver cancer.
The stats paint a very scary picture, but here at GMRF we see beyond the numbers and figures. The real impact of liver cancer is not in its numbers but in the countless lives it is devastating each day.
As we are based at Greenslopes Private Hospital and conduct a range of clinical trials in cancer treatment, we see firsthand this disease taking the lives of people who should have many years still ahead of them.
With your help, we are doing something about, and we have a very clear vision for our research…
We are committed to innovative research that can change cancer from a death sentence to a treatable chronic illness within our lifetime.
It’s an ambitious but achievable goal – with support. You can help fight this rapidly increasing cancer.
GMRF has the only dedicated liver cancer research facility in Queensland.
That is what your donation to GMRF can achieve – creating solutions to one of the biggest health issues our country, and indeed our world, is facing.
Head of the Liver Cancer Unit, Dr Jason Steel, describes the focus…
“At present there is only a single drug that can improve survival times of patients with liver cancer. It prolongs live by months and rarely cures the cancer. Many people do not respond to this treatment yet it is our best drug currently available. We need new treatments that can give hope to patients who have advanced liver disease. Our work looks at new ways to target and kill cancer with the hope that new treatments will come out of this work.”
We’re not the ‘all of the eggs in one basket’ types, which is why we have developed a multi-pronged approach when it comes to tackling liver cancer. Our current research focus is in three key areas
Development of a cancer killing virus: We are starting to test whether our new viruses can be used as a treatment for liver cancer. We will test whether they can specifically target and kill the cancer while leaving normal cells untouched.
Immunotherapy for liver cancer: we are examining new drug combinations to block and kill the cells that inhibit our immune system killing the cancer. We will start to look at combining these blocking agents with cancer vaccines.
Anti-metastatic therapies: We are evaluating new drugs we have identified that have the potential to block the spread of cancer. We will also attempt to find a number of new drugs that might also show these characteristics.